Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer
Status:
Completed
Trial end date:
2016-07-07
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and feasibility of oral rehydration
therapy for short hydration in patients with biliary tract cancer who will undergo the
chemotherapy including gemcitabine and cisplatin.